Sign inSubmit
ArticleMetrics
Research Article · Free to read · Published 31 October 2010

Comparative Docking Analysis on Natural Compounds Versus a Synthetic Drug as a Therapeutic for Acquired Immuno Deficiency Syndrome

Sandhya R. Nair1, R. Subhashini1 & B. Thiagarajan1

Current Research in Medicine, Volume 1, Issue 2, pp. 148–150 · doi.org/10.3844/amjsp.2010.148.150

7,323 accesses3,969 downloads0 citations (Crossref)Metrics
Cite Check for updates

Abstract

Problem statement: Acquired Immune Deficiency Syndrome (AIDS) is one of the worst pandemics affecting and spreading quickly all over the world with a high mortality rate. AIDS has been able to kill so many people due to the unique property of Human Immunodeficiency Virus (HIV) virus. It attacks the immune system of the victim there by not allowing the immune system to fight against the infection. Till today there has been no vaccine or medicine invented against AIDS and thus the syndrome remains incurable. Approach: In the present study, automated docking was performed by comparing two natural compounds namely ellagic acid, quercitine against a synthetic drug namely nevirapine on Cluster of Differentiation 4 (CD4), which serves as the high-affinity receptor for cellular attachment and entry of the HIV which is responsible for AIDS. Using the available Bioinformatics tools and techniques a comparative study between the natural and the synthetic drug was done. Results: From the results, it was found that the natural compounds showed more inhibiting activity towards CD4 than the already available drug. Perhaps the quercitine could be used as a potential lead compound that has an activity on the target and could be modified to improve its pharmaceutical features in the drug discovery process for AIDS. Conclusion: However the results from clinical studies were always the limiting step to the entrance of the novel drugs into the market. This research was an attempt to take a good step towards the drug discovery against AIDS.

Licence and reuse

Free to read. This article carries the publisher’s copyright, as printed on it: © 2010 Science Publications. It is free to read; ask us before reusing it.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Nair, S. R., Subhashini, R. & Thiagarajan, B. (2010). Comparative Docking Analysis on Natural Compounds Versus a Synthetic Drug as a Therapeutic for Acquired Immuno Deficiency Syndrome. Current Research in Medicine, 1(2), 148–150. https://doi.org/10.3844/amjsp.2010.148.150

Licence
© Science Publications
Issue
Volume 1, Issue 2
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
Comparative Docking Analysis on Natural Compounds Versus a Synthetic Drug as a Therapeutic for Acquired Immuno Deficiency SyndromeCurrent Research in Medicine · Volume 1, Issue 2 · pp. 148–150 · © Science PublicationsDownload